Yes, exactly! > "Securing control before releasing the massive news!"
Securing control before releasing the massive news!
Their patent is one of the best coronavirus patents I’ve seen.
Positive news could take us into high dollars with this SS.
How high is "high dollars"...? Lol...
On June 17, 2020, our Board of Directors authorized the issuance of Five Hundred Thousand (500,000) shares of our Series “B” Preferred Stock in favor of Dr. Steve N. Slilaty, our CEO and a director, in consideration for his development of a new treatment for Coronavirus infections, including COVID-19. The Series “B” Preferred Stock is non-convertible, non-redeemable, non-retractable and has a superior liquidation value of $0.10 per share. Each share of Series “B” Preferred Stock is entitled to 1,000 votes per share.